HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: 288/4/R863    most recent 00489.2004v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (6) Citing Articles via Google Scholar Google Scholar Articles by Thrasher, T. N. Search for Related Content PubMed PubMed Citation Articles by Thrasher, T. N.

CALL FOR PAPERS
Baroreflex Control of Sodium Excretion and Arterial Pressure

Effects of chronic baroreceptor unloading on blood pressure in the dog

Department of Surgery, School of Medicine, University of Maryland, Baltimore, Maryland

Submitted 22 July 2004 ; accepted in final form 23 November 2004

We have developed a new model of chronic baroreceptor unloading (CBU) in the dog. Initial characterization of the model indicated that CBU increased mean arterial pressure (MAP) by an average of 22 mmHg for 7 days. The goal of the present study was to replicate the previous study using telemetry to record MAP continuously and to determine the effects of CBU (n = 7) on chronic regulation of MAP. We also prepared a group of dogs with sinoaortic denervation (SAD, n = 6) to compare the time course of changes in MAP in the two models. Control levels (7 day average ± SE) of MAP in the CBU and SAD groups were 94 ± 2 and 94 ± 1 mmHg, respectively. MAP averaged 124 ± 8 and 103 ± 4 mmHg during the first and second weeks after SAD (both P < 0.05) and then declined to levels not different from control during weeks 3–5. In the CBU group, MAP averaged 120 ± 4 mmHg during the first week, declined to 111 ± 4 mmHg during the second week, and stabilized at 104 mmHg during weeks 3–5 (all P < 0.05 compared with control). Plasma norepinephrine levels were increased significantly for the first week after SAD and for 2 wk after CBU but were not different from control for the remainder of the study. These results indicate that the initial increase in MAP after CBU is not sustained but declines to a level that is modestly higher than control. However, because MAP did not fall to control levels, the results are compatible with the hypothesis that baroreceptor input can influence the long-term level of MAP.

neurogenic hypertension; arterial baroreceptors; plasma norepinephrine; renin; aldosterone

This article has been cited by other articles:

				T. E. Lohmeier, D. A. Hildebrandt, T. M. Dwyer, R. Iliescu, E. D. Irwin, A. W. Cates, and M. A. Rossing Prolonged Activation of the Baroreflex Decreases Arterial Pressure Even During Chronic Adrenergic Blockade Hypertension, May 1, 2009; 53(5): 833 - 838. [Abstract] [Full Text] [PDF]

				T. E. Lohmeier, D. A. Hildebrandt, T. M. Dwyer, A. M. Barrett, E. D. Irwin, M. A. Rossing, and R. S. Kieval Renal Denervation Does Not Abolish Sustained Baroreflex-Mediated Reductions in Arterial Pressure Hypertension, February 1, 2007; 49(2): 373 - 379. [Abstract] [Full Text] [PDF]

				V. L. Brooks, K. L. Freeman, and Y. Qi Time course of synergistic interaction between DOCA and salt on blood pressure: roles of vasopressin and hepatic osmoreceptors Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2006; 291(6): R1825 - R1834. [Abstract] [Full Text] [PDF]

				P. B. Persson Baroreflexes in Hypertension: A Mystery Revisited Hypertension, November 1, 2005; 46(5): 1095 - 1096. [Full Text] [PDF]

				V. L. Brooks and A. F. Sved Pressure to change? Re-evaluating the role of baroreceptors in the long-term control of arterial pressure Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2005; 288(4): R815 - R818. [Full Text] [PDF]

				T. N. Thrasher Baroreceptors, baroreceptor unloading, and the long-term control of blood pressure Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2005; 288(4): R819 - R827. [Abstract] [Full Text] [PDF]